About GoodRx Holdings, Inc. (GDRX): stock profile, AI score and financials
GoodRx Holdings, Inc. (GDRX) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. 13F Pro's AI-powered ranking engine scores GDRX at 47.5/100 on a composite quality score built from its SEC filings, placing it at rank #1,792 of 2,925 stocks — the bottom half of the AI-ranked universe. GDRX scores in the top quartile across earnings quality (94.3), free cash flow (79.3). Areas of concern include revenue growth (27.1) and profitability (34.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 16.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), GoodRx Holdings, Inc. reports quarterly revenue of $200.4M, net income of $8.5M, an operating margin of 11.8%. Top institutional holders of GDRX by reported 13-F value include Francisco Partners Management, LSV ASSET MANAGEMENT, AMERIPRISE FINANCIAL, based on the most recent SEC filings. GDRX trades on the Nasdaq exchange and files with the SEC under CIK 1809519. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GDRX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GoodRx Holdings, Inc. directly from SEC EDGAR.